{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:27:59Z","timestamp":1790004479299,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Dutch Alzheimer's Society","award":["WE.15-2014-01"],"award-info":[{"award-number":["WE.15-2014-01"]}]},{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","award":["n.a."],"award-info":[{"award-number":["n.a."]}],"id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13195-016-0228-4","type":"journal-article","created":{"date-parts":[[2017,1,10]],"date-time":"2017-01-10T12:20:02Z","timestamp":1484050802000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":109,"title":["Diagnostic impact of [18F]flutemetamol PET in early-onset dementia"],"prefix":"10.1186","volume":"9","author":[{"given":"Marissa D.","family":"Zwan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femke H.","family":"Bouwman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elles","family":"Konijnenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiesje M.","family":"van der Flier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan A.","family":"Lammertsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans R. J.","family":"Verhey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Aalten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart N. M.","family":"van Berckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Scheltens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,17]]},"reference":[{"key":"228_CR1","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.3233\/JAD-2010-1337","volume":"19","author":"EL Koedam","year":"2010","unstructured":"Koedam EL, Lauffer V, van der Vlies AE, van der Flier WM, Scheltens P, Pijnenburg YA. Early-versus late-onset Alzheimer\u2019s disease: more than age alone. J Alzheimers Dis. 2010;19:1401\u20138.","journal-title":"J Alzheimers Dis"},{"key":"228_CR2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3233\/JAD-2012-111934","volume":"30","author":"LL Smits","year":"2012","unstructured":"Smits LL, Pijnenburg YA, Koedam EL, van der Vlies AE, Reuling IE, Koene T, et al. Early onset Alzheimer\u2019s disease is associated with a distinct neuropsychological profile. J Alzheimers Dis. 2012;30:101\u20138.","journal-title":"J Alzheimers Dis"},{"key":"228_CR3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack Jr CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:263\u20139.","journal-title":"Alzheimers Dement"},{"key":"228_CR4","doi-asserted-by":"crossref","first-page":"e-16","DOI":"10.1016\/j.jalz.2013.05.012","volume":"9","author":"KA Johnson","year":"2013","unstructured":"Johnson KA, Minoshima S, Bohnen NI, Donohoe KJ, Foster NL, Herscovitch P, et al. Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer\u2019s Association. Alzheimers Dement. 2013;9:e-16.","journal-title":"Alzheimers Dement"},{"key":"228_CR5","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1159\/000339367","volume":"33","author":"CG Schipke","year":"2012","unstructured":"Schipke CG, Peters O, Heuser I, Grimmer T, Sabbagh MN, Sabri O, et al. Impact of beta-amyloid-specific florbetaben PET imaging on confidence in early diagnosis of Alzheimer\u2019s disease. Dement Geriatr Cogn Disord. 2012;33:416\u201322.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"228_CR6","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jalz.2012.07.003","volume":"9","author":"R Ossenkoppele","year":"2013","unstructured":"Ossenkoppele R, Prins ND, Pijnenburg YA, Lemstra AW, van der Flier WM, Adriaanse SF, et al. Impact of molecular imaging on the diagnostic process in a memory clinic. Alzheimers Dement. 2013;9:414\u201321.","journal-title":"Alzheimers Dement"},{"key":"228_CR7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/WAD.0b013e318279d02a","volume":"27","author":"M Grundman","year":"2013","unstructured":"Grundman M, Pontecorvo MJ, Salloway SP, Doraiswamy PM, Fleisher AS, Sadowsky CH, et al. Potential impact of amyloid imaging on diagnosis and intended management in patients with progressive cognitive decline. Alzheimer Dis Assoc Disord. 2013;27:4\u201315.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"228_CR8","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1159\/000345783","volume":"2","author":"KS Frederiksen","year":"2012","unstructured":"Frederiksen KS, Hasselbalch SG, Hejl AM, Law I, Hojgaard L, Waldemar G. Added diagnostic value of (11)C-PiB-PET in memory clinic patients with uncertain diagnosis. Dement Geriatr Cogn Dis Extra. 2012;2:610\u201321.","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"228_CR9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1212\/WNL.0000000000000032","volume":"82","author":"P Sanchez-Juan","year":"2014","unstructured":"Sanchez-Juan P, Ghosh PM, Hagen J, Gesierich B, Henry M, Grinberg LT, et al. Practical utility of amyloid and FDG-PET in an academic dementia center. Neurology. 2014;82:230\u20138.","journal-title":"Neurology"},{"key":"228_CR10","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1080\/13554794.2013.791867","volume":"20","author":"AS Zannas","year":"2014","unstructured":"Zannas AS, Doraiswamy PM, Shpanskaya KS, Murphy KR, Petrella JR, Burke JR, et al. Impact of (1)(8)F-florbetapir PET imaging of beta-amyloid neuritic plaque density on clinical decision-making. Neurocase. 2014;20:466\u201373.","journal-title":"Neurocase"},{"key":"228_CR11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1750-1326-9-10","volume":"9","author":"EM Mitsis","year":"2014","unstructured":"Mitsis EM, Bender HA, Kostakoglu L, Machac J, Martin J, Woehr JL, et al. A consecutive case series experience with [18\u00a0F] florbetapir PET imaging in an urban dementia center: impact on quality of life, decision making, and disposition. Mol Neurodegener. 2014;9:10.","journal-title":"Mol Neurodegener"},{"key":"228_CR12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3233\/JAD-132306","volume":"41","author":"WM Flier van der","year":"2014","unstructured":"van der Flier WM, Pijnenburg YA, Prins N, Lemstra AW, Bouwman FH, Teunissen CE, et al. Optimizing patient care and research: the Amsterdam Dementia Cohort. J Alzheimers Dis. 2014;41:313\u201327.","journal-title":"J Alzheimers Dis"},{"key":"228_CR13","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/brain\/awr179","volume":"134","author":"K Rascovsky","year":"2011","unstructured":"Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456\u201377.","journal-title":"Brain"},{"key":"228_CR14","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","volume":"43","author":"GC Roman","year":"1993","unstructured":"Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43:250\u201360.","journal-title":"Neurology"},{"key":"228_CR15","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J, Emre M, O\u2019Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65:1863\u201372.","journal-title":"Neurology"},{"key":"228_CR16","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1002\/ana.10570","volume":"54","author":"BF Boeve","year":"2003","unstructured":"Boeve BF, Lang AE, Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol. 2003;54:S15\u20139.","journal-title":"Ann Neurol"},{"key":"228_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","volume":"47","author":"I Litvan","year":"1996","unstructured":"Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996;47:1\u20139.","journal-title":"Neurology"},{"key":"228_CR18","first-page":"471","volume":"48","author":"S Surti","year":"2007","unstructured":"Surti S, Kuhn A, Werner ME, Perkins AE, Kolthammer J, Karp JS. Performance of Philips Gemini TF PET\/CT scanner with special consideration for its time-of-flight imaging capabilities. J Nucl Med. 2007;48:471\u201380.","journal-title":"J Nucl Med"},{"key":"228_CR19","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1532-5415.1999.tb02571.x","volume":"47","author":"A Lim","year":"1999","unstructured":"Lim A, Tsuang D, Kukull W, Nochlin D, Leverenz J, McCormick W, et al. Clinico-neuropathological correlation of Alzheimer\u2019s disease in a community-based case series. J Am Geriatr Soc. 1999;47:564\u20139.","journal-title":"J Am Geriatr Soc"},{"key":"228_CR20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/153331750401900309","volume":"19","author":"W Mok","year":"2004","unstructured":"Mok W, Chow TW, Zheng L, Mack WJ, Miller C. Clinicopathological concordance of dementia diagnoses by community versus tertiary care clinicians. Am J Alzheimers Dis Other Demen. 2004;19:161\u20135.","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"228_CR21","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/NEN.0b013e31824b211b","volume":"71","author":"TG Beach","year":"2012","unstructured":"Beach TG, Monsell SE, Philips LE, Kukall W. Accuracy of the clinical diagnosis of alzheimer disease at National Institute on Aging Alzheimer\u2019s Disease Centers, 2005\u20132010. J Neuropathol Exp Neurol. 2012;71:266\u201373.","journal-title":"J Neuropathol Exp Neurol"},{"key":"228_CR22","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.parkreldis.2014.02.012","volume":"20","author":"BN Dugger","year":"2014","unstructured":"Dugger BN, Adler CH, Shill HA, Caviness J, Jacobson S, Driver-Dunckley E, et al. Concomitant pathologies among a spectrum of parkinsonian disorders. Parkinsonism Relat Disord. 2014;20:525\u20139.","journal-title":"Parkinsonism Relat Disord"},{"key":"228_CR23","first-page":"398","volume":"58","author":"MD Zwan","year":"2014","unstructured":"Zwan MD, Okamura N, Fodero-Tavoletti MT, Furumoto S, Masters CL, Rowe CC, et al. Voyage au bout de la nuit: Abeta and tau imaging in dementias. Q J Nucl Med Mol Imaging. 2014;58:398\u2013412.","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"228_CR24","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1093\/brain\/aww159","volume":"139","author":"G Ch\u00e9telat","year":"2016","unstructured":"Ch\u00e9telat G, Ossenkoppele R, Villemagne VL, Perrotin A, Landeau B, M\u00e9zenge F, et al. Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer\u2019s disease. Brain. 2016;139:2528\u201339.","journal-title":"Brain"},{"key":"228_CR25","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00401-012-1051-z","volume":"124","author":"JO Rinne","year":"2012","unstructured":"Rinne JO, Wong DF, Wolk DA, Leinonen V, Arnold SE, Buckley C, et al. [(18)F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid beta detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies. Acta Neuropathol. 2012;124:833\u201345.","journal-title":"Acta Neuropathol"},{"key":"228_CR26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/2051-5960-2-46","volume":"2","author":"V Leinonen","year":"2014","unstructured":"Leinonen V, Rinne JO, Wong DF, Wolk DA, Trojanowski JQ, Sherwin PF, et al. Diagnostic effectiveness of quantitative [(1)(8)F]flutemetamol PET imaging for detection of fibrillar amyloid beta using cortical biopsy histopathology as the standard of truth in subjects with idiopathic normal pressure hydrocephalus. Acta Neuropathol Commun. 2014;2:46.","journal-title":"Acta Neuropathol Commun"},{"key":"228_CR27","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s11307-012-0583-x","volume":"15","author":"DF Wong","year":"2013","unstructured":"Wong DF, Moghekar AR, Rigamonti D, Brasic JR, Rousset O, Willis W, et al. An in vivo evaluation of cerebral cortical amyloid with [18\u00a0F]flutemetamol using positron emission tomography compared with parietal biopsy samples in living normal pressure hydrocephalus patients. Mol Imaging Biol. 2013;15:230\u20137.","journal-title":"Mol Imaging Biol"},{"key":"228_CR28","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1001\/jama.2015.4669","volume":"313","author":"R Ossenkoppele","year":"2015","unstructured":"Ossenkoppele R, Jansen WJ, Rabinovici GD, Knol DL, van der Flier WM, van Berckel BN, et al. Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. JAMA. 2015;313:1939\u201349.","journal-title":"JAMA"},{"key":"228_CR29","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.3233\/JAD-151180","volume":"52","author":"MR Bensaidane","year":"2016","unstructured":"Bensaidane MR, Beauregard JM, Poulin S, Buteau FA, Guimond J, Bergeron D, et al. Clinical utility of amyloid PET imaging in the differential diagnosis of atypical dementias and its impact on caregivers. J Alzheimers Dis. 2016;52:1251\u201362.","journal-title":"J Alzheimers Dis"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-016-0228-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T06:39:53Z","timestamp":1568702393000},"score":1,"resource":{"primary":{"URL":"http:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-016-0228-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,17]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["228"],"URL":"https:\/\/doi.org\/10.1186\/s13195-016-0228-4","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,17]]},"article-number":"2"}}